Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Crucial information lacking in chest pain referrals

09.03.2005


Important information that could optimise the diagnosis and management of chest pain patients is often lacking on referral between primary and secondary care, according to an influential multidisciplinary working group of the Angina Forum. In a bid to tackle the situation, the group has developed a template for use by both general practices and rapid access chest pain clinics (RACPCs).



The move follows a meeting of the Forum’s expert working group, which highlighted the major problems that can be caused when referrals of suspected angina patients, both to and from secondary care assessment, are not accompanied by adequate information. According to the group, this can result in delay, confusion, misdiagnosis and inappropriate treatment.

The consensus guidance provides a checklist for the essential information which should accompany suspected angina patients on referral to rapid access chest pain clinics and on their return to primary care. The list is also available as a pro-forma which can be adopted or modified for local variations.


Explaining the rationale behind the document, Angina Forum group member Professor Adam Timmis, consultant cardiologist at the London Chest Hospital, comments: “While there are clearly pockets of best practice, the quality of information following angina patients on their disease management journey is patchy. This consensus document has been developed in an attempt to spread best practice more widely and optimise the increasingly important role of chest pain clinics.”

According to the Department of Health, patients in all acute Trusts now have access to RACPCs,1 which were established as part of the National Service Framework for Coronary Heart Disease in 2000,2 and a majority of Trusts are now achieving the target maximum
waiting time of 14 days from referral to assessment.3 However, no clear guidelines exist on referral procedures.

The problem is often most pronounced when patients are returned to the care of their GP from secondary care, according to specialist GP Dr George Kassianos, also a member of the Forum’s working group. “Following the RACPC appointment, patients often return to the GP with no written information about diagnosis or treatment, and the GP has to rely on the patient’s recall of what they were told by the doctor they saw in the clinic,” he explains. “After the patient has been seen in the RACPC and is waiting for their next appointment, there is no protocol for the GP on what to watch for, how often the patient should be seen, or how to address the patient’s concerns about their condition.”

In developing its guidance, the Angina Forum group explored examples of best practice and arrived at a consensus regarding the information that should pass between primary and secondary care in cases of suspected angina. The template addresses many of the things often overlooked, such as family history and known intolerances to certain anti-anginal drugs. It also serves as a check to ensure that urgent cases, such as severe chest pain that occurs at rest or lasts longer than 20 minutes, are treated as emergencies and not referred to the chest pain clinics.

For patients referred back from the RACPC to the GP, the template will help ensure that a rational management plan is included. It will also identify when anti-anginal drugs have been stopped or new medical therapy initiated.

Copies of the checklist and referral form are available from the Angina Forum Secretariat, e-mail anginaforum@phaseiv.co.uk.

Sandra Batten | alfa
Further information:
http://www.phaseiv.co.uk

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Structured light and nanomaterials open new ways to tailor light at the nanoscale

23.04.2018 | Physics and Astronomy

On the shape of the 'petal' for the dissipation curve

23.04.2018 | Physics and Astronomy

Clean and Efficient – Fraunhofer ISE Presents Hydrogen Technologies at the HANNOVER MESSE 2018

23.04.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>